Familial thrombophilia associated with fibrinogen paris V: Dusart syndrome.
We report on a family with a history of venous thromboembolism associated with fibrinogen Paris V (fibrinogen Aalpha-Arg554-->Cys). Ten members experienced thrombotic events, including 4 with fatal pulmonary emboli. Pulmonary embolism was the presenting feature in 4. Those with the mutation and a history of thrombosis had somewhat higher fibrinogen concentrations than those with the mutation and no thrombosis (294 +/- 70 mg/dL vs 217 +/- 37 mg/dL, respectively). The Paris V mutation consistently caused a prolongation of the reptilase time, and fibrin clots containing the abnormal fibrinogen were more translucent than normal clots. Given the early onset of symptoms and the initial presentation with pulmonary embolism in some family members, it was justifiable to offer prophylactic anticoagulation with warfarin to carriers of the mutation. Fibrinogen Paris V has now been reported in 4 apparently unrelated families, indicating that it is a relatively common cause of dysfibrinogenemia-associated thrombosis.
Tarumi
T
T
Departments of Pathology, Medicine, and Pediatrics, Vanderbilt University, Nashville, TN 37232-6305, USA.
Martincic
D
D
Thomas
A
A
Janco
R
R
Hudson
M
M
Baxter
P
P
Gailani
D
D
D000293:Adolescent; D000328:Adult; D005260:Female; D015241:Fibrinogens, Abnormal / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D019851:Thrombophilia / Q000235:genetics*
D015241:Fibrinogens, Abnormal; C041265:fibrinogen Dusard